For more information, contact:
This is part of an ongoing series on the recipients of the MetroConnect Prize, presented by JP Morgan Chase, a grant awarded to 15 companies looking to expand into new foreign markets. Subscribe here to receive new posts every Wednesday on this topic.
“Global SaaS software revenues are forecasted to reach $106B in 2016, increasing 21 over projected 2015 spending levels.” - Louis Columbus, contributor, Forbes
According to Cisco®’s Global Cloud Index, “By 2018, more than three quarters (78 percent) of workloads will be processed by cloud data centers…22 percent will be processed by traditional data centers.” The growth of cloud-based systems over the next three to five years will be exponential, leading many companies to implement these technologies into their companies for ease of use.
One sector which could benefit from this technology is the healthcare industry, giving hospitals the opportunity to seamlessly integrate data into the patient experience . Data management from drug treatments and lifestyle can be streamed in real-time to a doctor.
Enter VisionTree Software’s Optimal Care platform.
VisionTree was founded more than 12 years ago by its current CEO, Martin Pellinat. VisionTree is a leader in data collection, workflow integration, and cross platform applications for improved quality and efficiency of the communication, decision making, and planning processes within the healthcare system.
Pellinat and his team have worked with many of San Diego’s innovative medical centers with the VisionTree software. They have worked with the Scripps Proton Therapy Center to improve its workflow for its leading edge cancer treatment program, and UC San Diego’s health system for both research and clinical use for patient-centered outcomes.
“San Diego is known for medical, life sciences and technology innovations,” said Pellinat. “It is because of this, that VisionTree continues to attract a leading software engineering team to work at its headquarters in San Diego.”
The success of the region’s small- and medium-sized companies is critical to the region’s future, and increasing their global reach is crucial to that success. Through the MetroConnect Prize, made possible by JPMorgan Chase, companies such as VisionTree received $10,000 grants to assist with their next step in going global.
VisionTree is using the MetroConnect funds to expand its software platform to deliver an interoperable solution with all electronic health records in international markets. This integration allows the software to be used more effectively.
“VisionTree is focused on the Australia and European markets,” said Pellinat. “Certain markets are launching national cancer registries and the VTOC platform has been proven in the U.S. with its data-collection elements and workflow system (e.g. prostate, breast, lung, brain) for scalable, multi-center, cloud-based deployments in these new global markets."
Subscribe here to receive new posts every Wednesday on this topic.